메뉴 건너뛰기




Volumn 27, Issue 9, 2011, Pages 1425-1430

Treatment of pediatric refractory status epilepticus with topiramate

Author keywords

Children; Epilepsy; Refractory; Topiramate

Indexed keywords

DIAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

EID: 80054744146     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-011-1432-y     Document Type: Article
Times cited : (28)

References (24)
  • 1
    • 43449091883 scopus 로고    scopus 로고
    • Treatment of Refractory Status Epilepticus: Literature Review and a Proposed Protocol
    • DOI 10.1016/j.pediatrneurol.2008.01.001, PII S0887899408000349
    • Abend NS, Dlugos DJ (2008) Treatment of refractory status epilepticus: literature review and proposed protocol. Pediatr Neurol 38:377-390 (Pubitemid 351671983)
    • (2008) Pediatric Neurology , vol.38 , Issue.6 , pp. 377-390
    • Abend, N.S.1    Dlugos, D.J.2
  • 2
    • 0346787771 scopus 로고    scopus 로고
    • Topiramate and status epilepticus: Report of three cases
    • DOI 10.1016/j.yebeh.2003.07.016
    • Bensalem MK, Fakhoury TA (2003) Topiramate and status epilepticus: report ofthree cases. Epilepsy Behav 4:757-760 (Pubitemid 38035702)
    • (2003) Epilepsy and Behavior , vol.4 , Issue.6 , pp. 757-760
    • Bensalem, M.K.1    Fakhoury, T.A.2
  • 3
    • 0036126825 scopus 로고    scopus 로고
    • Refractory status epilepticius 2001
    • Bleck TP (2002) Refractory status epilepticius 2001. Arch Neurol 59:188-189
    • (2002) Arch Neurol , vol.59 , pp. 188-189
    • Bleck, T.P.1
  • 5
    • 0037816146 scopus 로고    scopus 로고
    • Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients
    • DOI 10.1046/j.1528-1157.2003.64402.x
    • Doose DR, Brodie MJ, Wilson EA et al (2003) Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients. Epilepsia 44:917-922 (Pubitemid 36842181)
    • (2003) Epilepsia , vol.44 , Issue.7 , pp. 917-922
    • Doose, D.R.1    Brodie, M.J.2    Wilson, E.A.3    Chadwick, D.4    Oxbury, J.5    Berry, D.J.6    Schwabe, S.7    Bialer, M.8
  • 6
    • 0029804193 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug
    • Doose DR, Walker SA, Gisclon LG, Nayak RK (1996) Single-dose pharmokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 36:884-891 (Pubitemid 26384477)
    • (1996) Journal of Clinical Pharmacology , vol.36 , Issue.10 , pp. 884-891
    • Doose, D.R.1    Walker, S.A.2    Gisclon, L.G.3    Nayak, R.K.4
  • 7
    • 0000844483 scopus 로고
    • Evaluation of phenobarbital and primidone/phenobarbital plasma concentrations during administration of add-on topiramate theraphy in five multicenter, double-blind, placebo-controlled in ourpatients with partial seizures
    • Doose DR, Walker SA, Pledger G (1995) Evaluation of phenobarbital and primidone/phenobarbital plasma concentrations during administration of add-on topiramate theraphy in five multicenter, double-blind, placebo-controlled in ourpatients with partial seizures. Epilepsia 36(suppl 3):158
    • (1995) Epilepsia , vol.36 , Issue.SUPPL. 3 , pp. 158
    • Doose, D.R.1    Walker, S.A.2    Pledger, G.3
  • 8
    • 0029922566 scopus 로고    scopus 로고
    • Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
    • Faught E, Wilder BJ, Ramsay RE, ReifeRA KLD, Pledger GW, Karim RM (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400- and, 600-mg daily dosages. Topiramate YD Study Group Neurology 46:1684-1690 (Pubitemid 26185793)
    • (1996) Neurology , vol.46 , Issue.6 , pp. 1684-1690
    • Faught, E.1    Wilder, B.J.2    Ramsay, R.E.3    Reife, R.A.4    Kramer, L.D.5    Pledger, G.W.6    Karim, R.M.7
  • 9
    • 58149154641 scopus 로고    scopus 로고
    • Levatiracetam in children with refractory status epilepticus
    • Gallentine WB, Hunnicut AS, Husain AM (2009) Levatiracetam in children with refractory status epilepticus. Epilepsy Behav 14:215-218
    • (2009) Epilepsy Behav , vol.14 , pp. 215-218
    • Gallentine, W.B.1    Hunnicut, A.S.2    Husain, A.M.3
  • 10
    • 67349108919 scopus 로고    scopus 로고
    • Topiramate
    • In: Pellock JM, Bourgeois BF, Dodson WE (eds Demos Medical Publishing, New York
    • Glauser TA (2008) Topiramate. In: Pellock JM, Bourgeois BF, Dodson WE (eds) Pediatric epilepsy diagnosis and therapy, 3rd edn. Demos Medical Publishing, New York, pp 671-683
    • (2008) Pediatric Epilepsy Diagnosis and Therapy, 3rd Edn , pp. 671-683
    • Glauser, T.A.1
  • 11
    • 33947175991 scopus 로고    scopus 로고
    • The anaesthetic and intensive care of status epilepticus
    • DOI 10.1097/WCO.0b013e328042bacb, PII 0001905220070400000012
    • Holtkamp M (2007) The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 20:188-193 (Pubitemid 46411505)
    • (2007) Current Opinion in Neurology , vol.20 , Issue.2 , pp. 188-193
    • Holtkamp, M.1
  • 12
    • 0142072683 scopus 로고    scopus 로고
    • Efficacy of Topiramate in Children with Refractory Status Epilepticus
    • DOI 10.1046/j.1528-1157.2003.11803.x
    • Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A (2003) Efficiacy oftopiramate in children with refractory status epilepticus. Epilepsia 44:1353-1356 (Pubitemid 37280381)
    • (2003) Epilepsia , vol.44 , Issue.10 , pp. 1353-1356
    • Kahriman, M.1    Minecan, D.2    Kutluay, E.3    Selwa, L.4    Beydoun, A.5
  • 13
    • 24944482457 scopus 로고    scopus 로고
    • Refractory generalised convulsive status epilepticus: A guide to treatment
    • DOI 10.2165/00023210-200519090-00003
    • Kalvainen R, Eriksson K, Parvainen I (2005) Refractory generalized status epilepticus: a guide to treatment. CNS Drug 19:759-768 (Pubitemid 41324063)
    • (2005) CNS Drugs , vol.19 , Issue.9 , pp. 759-768
    • Kalviainen, R.1    Eriksson, K.2    Parviainen, I.3
  • 15
    • 0000892632 scopus 로고
    • Estimation of the absolute bioavailability oftopiramate in humans without intravenous data
    • Nayak RK, Gisclon LG, Curtin CA (1994) Estimation of the absolute bioavailability oftopiramate in humans without intravenous data. J Clin Pharmacol 34:1029
    • (1994) J Clin Pharmacol , vol.34 , pp. 1029
    • Nayak, R.K.1    Gisclon, L.G.2    Curtin, C.A.3
  • 16
    • 0033533162 scopus 로고    scopus 로고
    • Topiramate reduces neuronal injury after experimental status epilepticus
    • DOI 10.1016/S0006-8993(99)01615-7, PII S0006899399016157
    • Niebauer M, Gruenthal M (1999) Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 837:263-269 (Pubitemid 29369240)
    • (1999) Brain Research , vol.837 , Issue.1-2 , pp. 263-269
    • Niebauer, M.1    Gruenthal, M.2
  • 17
    • 33744498652 scopus 로고    scopus 로고
    • Use of midazolam for refractory status epilepticus in pediatric patients
    • Pellock JM (1999) Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol 20:259-264
    • (1999) J Child Neurol , vol.20 , pp. 259-264
    • Pellock, J.M.1
  • 18
    • 33744493123 scopus 로고    scopus 로고
    • Topiramate loading for refractory status epilepticus in children
    • DOI 10.1111/j.1528-1167.2006.00564.x
    • Perry MS, Holt PJ, Sladky JT (2006) Topiramate loading for status epilepticus in children. Epilepsia 47:1070-1071 (Pubitemid 43801519)
    • (2006) Epilepsia , vol.47 , Issue.6 , pp. 1070-1071
    • Perry, M.S.1    Holt, P.J.2    Sladky, J.T.3
  • 19
    • 0029884747 scopus 로고    scopus 로고
    • Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
    • Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-,800-and, 1000-mg daily dosages. Topiramate YE Study Group Neurology 46:1678-1683 (Pubitemid 26185792)
    • (1996) Neurology , vol.46 , Issue.6 , pp. 1678-1683
    • Privitera, M.1    Fincham, R.2    Penry, J.3    Reife, R.4    Kramer, L.5    Pledger, G.6    Karim, R.7
  • 20
    • 0029845689 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy
    • Sachdeo RC, Sachdeo SK, Walker SA, Kramer LD, Nayak RK, Doose DR (1996) Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 37:774-780 (Pubitemid 26276948)
    • (1996) Epilepsia , vol.37 , Issue.8 , pp. 774-780
    • Sachdeo, R.C.1    Sachdeo, S.K.2    Walker, S.A.3    Kramer, L.D.4    Nayak, R.K.5    Doose, D.R.6
  • 21
    • 0035213619 scopus 로고    scopus 로고
    • Outcome of severe refractory status epilepticus in children
    • Sahin M, Menache CC, Holmes GL (2001) Outcome of severe refractory status epilepticus in children. Epilepsia 42:1411-1467
    • (2001) Epilepsia , vol.42 , pp. 1411-1467
    • Sahin, M.1    Menache, C.C.2    Holmes, G.L.3
  • 24
    • 0242655295 scopus 로고    scopus 로고
    • Topiramate: As Monotherapy in Newly Diagnosed Epilepsy
    • DOI 10.2165/00023210-200317130-00007
    • Waugh J, Goa KL (2003) Topiramate: as monotheraphy in newly diagnosed epilepsy. CNS Drugs 17:985-992 (Pubitemid 37410073)
    • (2003) CNS Drugs , vol.17 , Issue.13 , pp. 985-992
    • Waugh, J.1    Goa, K.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.